Orca-T
Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 1
- Enrollment
- 24 patients (estimated)
- Sponsors
- Stanford University Cancer Institute (Palo Alto)
- Collaborators
- Incyte Corporation
- Tags
- Allogeneic Stem Cell Transplant, T Cell (Allogeneic)
- Trial Type
- Treatment
- Last Update
- SparkCures ID
- 1981
- NCT Identifier
- NCT06551584
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.